Piramal Life Sciences
BSE: 532979 | NSE: PIRLIFE | ISIN: INE122J01015 | Pharmaceuticals
 |
 |
Yearly Results of Piramal Life Sciences |
------------------- in Rs. Cr. ------------------- |
| |||||||
|
|||||||
| Mar '08 | Mar '09 | ||||||
|
|||||||
| Sales Turnover | -- | 2.29 | |||||
| Other Income | 0.06 | -- | |||||
| Total Income | 0.06 | 2.29 | |||||
| Total Expenses | 82.61 | 93.01 | |||||
| Operating Profit | -82.61 | -90.72 | |||||
| Profit On Sale Of Assets | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | |||||
| VRS Adjustment | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | |||||
| Gross Profit | -82.55 | -90.72 | |||||
| Interest | -0.15 | 9.52 | |||||
| PBDT | -82.40 | -100.24 | |||||
| Depreciation | 9.07 | 9.80 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | |||||
| PBT | -91.47 | -110.04 | |||||
| Tax | 0.23 | 0.81 | |||||
| Net Profit | -91.70 | -110.85 | |||||
| Prior Years Income/Expenses | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | |||||
| Dividend | -- | -- | |||||
| Dividend Tax | -- | -- | |||||
| Dividend (%) | -- | -- | |||||
| Earnings Per Share | -- | -- | |||||
| Book Value | -- | -- | |||||
| Equity | 25.45 | 25.45 | |||||
| Reserves | 158.21 | 158.21 | |||||
| Face Value | 10.00 | 10.00 | |||||
| |||||||
| Source : Religare Technova | |||||||
| Explore Piramal Life connections | |||||||
| |||||||
